Deployment: 360Passenger Status:PublicPassengerChecking status…
The Modern Living Peace Train™. How everything connects. FOLLOW, THE ORANGE. A train travels through a living landscape at sunrise.
FOLLOW, THE ORANGE!Search the publication

The Modern LivingPeace Train™

REAL CONNECTIONS.
A HEALTHIER TOMORROW.

SEE HOW EVERYTHING CONNECTS.

Investigating how our choices shape people, places
and the living systems we all depend on.

THE ENERGY OF LIVING · CONNECTED CONDITION JOURNEY

The Energy of Living →

The Modern Living Fountain of Youth™A new discovery begins

The Modern Living Fountain of Youth™ — Original creative concept and direction by the Founder of The Modern Living Peace Train™.

ALS: connecting specialist care with the life a person wants to live

Amyotrophic Lateral Sclerosis · Food, normal function and supported decisions

A conceptual branching signal pathway introduces motor nerves and muscle function. It is not a full nervous-system map or a prediction of progression.
Original explanatory schematic; not diagnostic imageryA conceptual branching signal pathway introduces motor nerves and muscle function. It is not a full nervous-system map or a prediction of progression.Illustration context: medlineplus.gov ↗
  1. Motor nerves
  2. Muscle function
  3. Individual support

Amyotrophic lateral sclerosis affects motor neurons, the nerve cells that signal voluntary muscles. It can affect movement, speech, swallowing and breathing. ALS is a specific diagnosis within the wider motor-neuron disease group; a symptom or a different motor-neuron condition should not be relabeled ALS without specialist assessment. [ALS-NLM]

Explore the Energy Anatomy connections.

These associations belong to the publication’s Energy Anatomy framework; they are not treatments or evidence of a food effect.

Primary connection: Brow →

Sources and review scope

These source notes explain the evidence consulted and its limits. Educational information does not replace individual medical care.

ALS-FDA
FDA: SOD1-ALS tofersen approval

Action; Effectiveness; accelerated approval; Safety information · Targeted accessible source text read; not a professional clinical appraisal or individualized recommendation.

Accessed 11 November 2026. 25 April 2023 approval context; no claim this is the newest evidence

ALS-MFR
Biogen: Qalsody indication and safety

Indication; Important safety information · Targeted accessible source text read; not a professional clinical appraisal or individualized recommendation.

Accessed 11 November 2026. Current manufacturer page read 11 November 2026; promotional source, targeted indication/safety only; not independent efficacy evidence

ALS-NLM
MedlinePlus: ALS

Summary; motor neurons; symptoms; diagnosis; treatment · Targeted accessible source text read; not a professional clinical appraisal or individualized recommendation.

Accessed 11 November 2026. Last updated 4 November 2026; targeted ALS-specific overview

BREATH
NHS: Shortness of breath

Immediate action and urgent advice; same-day retained source read · Targeted accessible source text read; not a professional clinical appraisal or individualized recommendation.

Accessed 11 November 2026. Reviewed 30 January 2024; next review 30 January 2027; same-day source check reused

ALS-PI
Qalsody (tofersen) prescribing information (PDF; revised April 2023)

§1 indication; §§5.1–5.3 warnings; §14 clinical studies, PDF pages 10–13 · Manufacturer-linked US prescribing information; targeted indication, serious warning and trial endpoint sections read independently for editorial/source accuracy. Not clinical appraisal or a complete regulatory-history audit.

Accessed 11 November 2026 through the manufacturer prescribing-information link. Label revision is April 2023; no claim of a new 2026 revision.

The journey continues beneath the surface.

Continue with Passenger depth for the condition, care questions and practical connections.

Continue as a Passenger →